Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon contact icon menu icon
Medicilon Logo
|
search icon close search icon contact icon menu icon
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events

Featured Stories

Hot information:
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Nov 03,2016
New Cancer Therapy: Food Poisoning?
    While bacteriotherapy may sound like some new age skin treatment or colon cleanse that you hear about as part of a new Hollywood diet trend on late night infomercials, it is, in fact, a sound medical tool that researchers and clinicians utilize to treat disease. "Bacteriotherapy is the use of live bacteria as therapy toRead more
More
New Cancer Therapy: Food Poisoning?
Nov 03,2016
Autism Spectrum Disorder Linked to Mutations in Mitochondrial DNA
In recent years, ongoing research has continually shown that an increased number of autism spectrum disorder (ASD) cases are inextricably linked to greater numbers of harmful mutations within mitochondrial DNA (mtDNA) than other unaffected members of their immediate family—yet, the biological basis for this relationship has remained unclear. Now, investigators at Cornell University in IthacaRead more
More
Nov 03,2016
Pharmaceutical Residual Rolvents Testing Labs
Medicilon provides expert, rapid analysis of all three classes of residual solvents. Our USP/ICH compliant, state-of-the-art laboratory, and experienced team of scientists allow you to manage the large number of methods that may be involved in identification and quantification of impurities, including residual solvents. Whether you have impurities that are being introduced in upstream stepsRead more
More
Pharmaceutical Residual Rolvents Testing Labs
Nov 02,2016
Proteomics Technique Identifies Two New Drug Targets for Treating Atherosclerosis
    Scientists at Brigham and Women’s Hospital say they have found two new potential drug targets for treating arterial diseases such as atherosclerosis. By using proteomics to screen a vast number of molecules, the researchers identified PARP9 and PARP14, two members of the poly(ADP-ribose) polymerase (PARP) family of proteins, as regulators of macrophage activation, which hasRead more
More
Nov 02,2016
Human Genome Modeled in 3D via Proximity Pair Analysis
    A shortcut has been found that may hasten the arrival of a genomics that is not just sequence-smart, but also shape-smart. The shortcut is possible because of proximity pairs, known chromosome–chromosome contact propensities, which may be catalogued by means of the Hi-C chemical–physical technique. By accounting for proximity pairs, researchers based at the International SchoolRead more
More
Nov 01,2016
Trace Metals Analysis in Pharmaceuticals
Medicilon's process analytical sciences group provides support for research, development, and commercial production. At Medicilon, the importance of analytical support in pharmaceutical development and manufacturing is well understood. We provide our clients with analytical method development and all other services required to support their regulatory needs. Services Offered Analytical Method Development, Qualification and Validation ForRead more
More
Trace Metals Analysis in Pharmaceuticals
Nov 01,2016
Big Improvement for Immunotherapy Could Come from Small Molecule
    The importance of cytotoxic T cells—colloquially known as killer T cells—in destroying cancer cells cannot be overstated. Our immune system employs an army of these specialist immune cells to protect the body from external threats, such as invading viruses and bacteria, as well as from internal threats, such as malignant tumor cells. Researchers are tryingRead more
More
Nov 01,2016
Targeted Therapies Offer Hope to Children with Brain Cancer
    More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer.  Researchers at Huntsman Cancer Institute (HCI) at the University of Utah write in Cell Reports ("MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells”) that they have identifiedRead more
More
Targeted Therapies Offer Hope to Children with Brain Cancer
Nov 01,2016
2016 Recombinant Protein and Antibody Drug R&D Seminar
    China Pharmaceutical University and Hefei Chaohu Economic Development Zone successfully co-hosted the "2016 Recombinant Protein and Antibody Drug R&D Seminar” at Shenye Holiday Inn Hot Spring Resort recently.  Medicilon congratulated the successful hosting of the seminar and sincerely thanked all the colleagues and peers from the pharmaceutical industry who attended this seminar for their sharing.
More
2016 Recombinant Protein and Antibody Drug R&D Seminar
Oct 31,2016
New Gene-Editing Technology Successfully Cures a Genetic Blood Disorder in Mice
    In gene editing, the kindest cut may be no cut at all. This possibility was explored by researchers working with peptide nucleic acids (PNAs), synthetic molecules that combine a protein-like backbone with the nucleobases found in DNA and RNA.     A next-generation gene-editing system has successfully cured a genetic blood disorder in living mice using aRead more
More